Pharma Stulln Gmbh opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Pharma Stulln Gmbh

Patent Number:
Title:
Atropine Pharmaceutical Compositions
Applicant:
Opposition Date:
Aug 9, 2022
Patent Number:
Title:
Ophthalmological Composition
Opposition Date:
Jun 9, 2022
Patent Number:
Title:
Phosphate-Free Pharmaceutical Composition For The Treatment Of Glaucoma
Opposition Date:
Apr 17, 2018

Want to track Pharma Stulln Gmbh?

Feel free to send us a message here and we will get back to you